NANECH.ST NanoEcho AB (publ)

Healthcare Biotechnology Stockholm Exchange
0.0130 SEK
Close of Oct 13, 2026
0.0128 0.1050
Market cap
SEK 6.11M
P/E
-
P/B
0.43x
ROE
-123.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is NANECH.ST undervalued?

Graham number

The Graham number of NanoEcho AB (publ) cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NanoEcho AB (publ) fundamental analysis

No fundamental analysis for NanoEcho AB (publ) yet.

NanoEcho AB (publ) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NanoEcho AB (publ)

NanoEcho AB (publ) engages in developing a new diagnostic method to determine the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is headquartered in Lund, Sweden.

Full company profile